6-42173762-C-T

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_001384910.1(GUCA1A):​c.149C>T​(p.Pro50Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00148 in 1,614,150 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 0 hom. )

Consequence

GUCA1A
NM_001384910.1 missense

Scores

8
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:1B:3

Conservation

PhyloP100: 2.64
Variant links:
Genes affected
GUCA1A (HGNC:4678): (guanylate cyclase activator 1A) This gene encodes an enzyme that plays a role in the recovery of retinal photoreceptors from photobleaching. This enzyme promotes the activity of retinal guanylyl cyclase-1 (GC1) at low calcium concentrations and inhibits GC1 at high calcium concentrations. Mutations in this gene can cause cone dystrophy 3 and code-rod dystrophy 14. provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.029534549).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00125 (190/152320) while in subpopulation NFE AF= 0.00204 (139/68036). AF 95% confidence interval is 0.00177. There are 1 homozygotes in gnomad4. There are 83 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 190 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GUCA1ANM_001384910.1 linkuse as main transcriptc.149C>T p.Pro50Leu missense_variant 1/4 ENST00000372958.2 NP_001371839.1
GUCA1ANB-GUCA1ANM_001319061.2 linkuse as main transcriptc.149C>T p.Pro50Leu missense_variant 3/6 NP_001305990.1
GUCA1ANB-GUCA1ANM_000409.5 linkuse as main transcriptc.149C>T p.Pro50Leu missense_variant 3/6 NP_000400.2
GUCA1ANB-GUCA1ANM_001319062.2 linkuse as main transcriptc.149C>T p.Pro50Leu missense_variant 2/5 NP_001305991.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GUCA1AENST00000372958.2 linkuse as main transcriptc.149C>T p.Pro50Leu missense_variant 1/41 NM_001384910.1 ENSP00000362049 P1

Frequencies

GnomAD3 genomes
AF:
0.00125
AC:
190
AN:
152202
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000579
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00204
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00118
AC:
298
AN:
251478
Hom.:
0
AF XY:
0.00105
AC XY:
143
AN XY:
135918
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.00197
Gnomad ASJ exome
AF:
0.000198
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000739
Gnomad NFE exome
AF:
0.00173
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.00150
AC:
2199
AN:
1461830
Hom.:
0
Cov.:
31
AF XY:
0.00139
AC XY:
1013
AN XY:
727214
show subpopulations
Gnomad4 AFR exome
AF:
0.000418
Gnomad4 AMR exome
AF:
0.00203
Gnomad4 ASJ exome
AF:
0.000115
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.000711
Gnomad4 NFE exome
AF:
0.00178
Gnomad4 OTH exome
AF:
0.00101
GnomAD4 genome
AF:
0.00125
AC:
190
AN:
152320
Hom.:
1
Cov.:
33
AF XY:
0.00111
AC XY:
83
AN XY:
74476
show subpopulations
Gnomad4 AFR
AF:
0.000577
Gnomad4 AMR
AF:
0.00118
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000377
Gnomad4 NFE
AF:
0.00204
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00160
Hom.:
2
Bravo
AF:
0.00120
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00116
AC:
10
ExAC
AF:
0.00103
AC:
125
EpiCase
AF:
0.00180
EpiControl
AF:
0.00219

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 10, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJan 03, 2017The P50L variant in the GUCA1A gene has been reported previously in three members of a family with variable ocular abnormalities, ranging from minimal macular involvement to moderately severe cone-rod dystrophy (Downes et al., 2001). The P50L variant was also identified in a patient with cone and cone-rod dystrophy, however, informative familial segregation data was not included to confirm if this variant occurred de novo or was inherited in this individual (Boulanger-Scemama et al., 2015). The NHLBI ESP Exome Sequencing Project reports P50L was observed in 0.12% (10/8600) alleles from individuals of European American ancestry, indicating it may be a rare (benign) variant in this population. The P50L variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved in mammals. One in vitro functional study concluded that this variant results in impaired calcium binding, however, enzyme assays showed similar results for the P50L variant compared to wild type enzyme, and it is unclear how this variant impacts the protein function (Sokal et al., 2000). In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We now interpret P50L as a variant of uncertain significance. -
Likely benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Usher syndrome Pathogenic:1
Pathogenic, no assertion criteria providedresearchDepartment of Clinical Genetics, Copenhagen University Hospital, RigshospitaletApr 01, 2018- -
Cone dystrophy 3 Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMJan 01, 2001- -
Macular dystrophy Pathogenic:1
Pathogenic, no assertion criteria providedresearchDepartment of Clinical Genetics, Copenhagen University Hospital, RigshospitaletApr 01, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.050
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.52
.;.;D;D;D
Eigen
Benign
0.12
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.81
.;T;.;.;T
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.030
T;T;T;T;T
MetaSVM
Benign
-0.66
T
MutationAssessor
Benign
1.9
.;.;L;L;L
MutationTaster
Benign
1.0
A;A;A;A
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-4.0
D;.;D;D;D
REVEL
Uncertain
0.44
Sift
Benign
0.13
T;.;T;T;T
Sift4G
Benign
0.35
T;T;T;T;T
Polyphen
0.13
.;.;B;B;B
Vest4
0.37, 0.16, 0.15, 0.16
MVP
0.83
MPC
0.25
ClinPred
0.030
T
GERP RS
5.8
Varity_R
0.21
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs104893968; hg19: chr6-42141500; COSMIC: COSV50003654; API